A 48-year-old woman from urban Delhi attends her local ASHA worker's clinic for routine check-up. She has a 5-year history of type 2 diabetes managed with metformin 500 mg BD and a 7-year history of hypertension on amlodipine 5 mg OD. Her current BP is 148/92 mmHg, fasting blood glucose 156 mg/dL, and BMI 28.5 kg/m². She reports poor medication adherence due to cost and forgetfulness. The ASHA worker counsels her on lifestyle modification and refers her to the ANM at the sub-centre for structured follow-up. According to NPCDCS protocol, which of the following is the MOST appropriate next step in the management of this patient at the sub-centre level?

Explanation

## NPCDCS Management at Sub-Centre Level — Role of ANM **Key Point:** The **sub-centre is the frontline of NCD management** under NPCDCS. The ANM (Auxiliary Nurse Midwife) is trained to perform **screening, basic assessment, health education, and medication adherence support** for stable, non-complicated NCDs. The sub-centre is **NOT** a prescribing unit for advanced pharmacotherapy or specialist investigations. ### NPCDCS Tier-Based Roles | Level | Role | Scope | |-------|------|-------| | **Sub-Centre (ANM/ASHA)** | Screening, assessment, counselling, adherence support | BP monitoring, blood glucose (point-of-care), anthropometry, lifestyle counselling, medication adherence | | **PHC (Health Worker/Doctor)** | Diagnosis, initiation of first-line therapy, management of stable cases | Antihypertensives, metformin, basic investigations, referral of complicated cases | | **District Hospital (Specialist)** | Diagnostic confirmation, management of complications, advanced therapy | Echocardiography, HbA1c, lipid profile, insulin initiation in uncontrolled diabetes, management of CV events | **High-Yield:** NPCDCS emphasizes **task-shifting** and **decentralization** — ANMs are trained to manage **stable, uncomplicated** NCDs through **non-pharmacological interventions** and **adherence support**. Pharmacological escalation and specialist investigations occur at PHC/district hospital level. ### Why This Patient Needs Sub-Centre-Level Management (Not Escalation Yet) **Current clinical status:** - Type 2 diabetes on monotherapy (metformin) — **not optimally controlled** (FBG 156 mg/dL) but **not acute/complicated** - Hypertension on monotherapy (amlodipine) — **suboptimal control** (BP 148/92) but **no end-organ damage evident** - **Primary problem:** Poor medication adherence due to cost and forgetfulness - **BMI 28.5:** Overweight — amenable to lifestyle intervention **Sub-centre intervention (ANM):** 1. **Baseline assessment:** - Repeat BP measurement (at least 2–3 readings on different days) - Point-of-care blood glucose testing - Anthropometry (weight, height, waist circumference) - Assessment of adherence barriers 2. **Health education & counselling:** - Dietary modification (reduced salt, refined carbohydrates; increased fibre) - Physical activity (150 min/week moderate-intensity exercise) - Weight loss target (5–10% reduction) - **Medication adherence strategies:** Pill organizers, reminders, cost-effective generic formulations - Complication awareness (signs of hypoglycaemia, hypertensive crisis) 3. **Structured follow-up:** - Monthly visits for BP/glucose monitoring and reinforcement of counselling - **Reassessment at 3 months:** If BP and glucose improve with adherence, continue sub-centre management; if no improvement despite adherence, refer to PHC for pharmacological escalation **Clinical Pearl:** The **majority of NCD patients (70–80%) can be managed at sub-centre/PHC level** with lifestyle modification and first-line drugs. Only **10–15% require specialist care** for complications or refractory disease. This patient's poor control is primarily due to **adherence**, not disease severity — the sub-centre is the ideal setting to address this. ### Why Other Options Are Incorrect - **Option A (Insulin + second antihypertensive at sub-centre):** ANMs are **not trained or authorized** to prescribe insulin or add second-line antihypertensives. This requires PHC-level assessment and prescription. - **Option C (Immediate district hospital referral):** Premature escalation. The patient is **stable and uncomplicated**; there is **no evidence of acute complications** (no DKA, no hypertensive emergency, no acute MI). Referral is indicated only after PHC-level optimization fails. - **Option D (HbA1c, lipid profile, GLP-1 agonist at sub-centre):** Sub-centres **lack laboratory capacity** for HbA1c and lipid testing. GLP-1 agonists are **specialist-level drugs** and cannot be prescribed at sub-centre. These investigations and drugs are PHC/district hospital domain.